← Back to Search

Radiation

UVA1 radiation treatment for Cutaneous Lupus Erythematosus

N/A
Waitlist Available
Led By Benjamin F Chong, MD, MSCS
Research Sponsored by Ben Chong
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights

Study Summary

This study is evaluating whether a type of light therapy may help treat cutaneous lupus.

Eligible Conditions
  • Cutaneous Lupus Erythematosus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cutaneous Lupus Disease Area and Severity Index (CLASI) Activity Score
Secondary outcome measures
Change in Cutaneous Lupus Disease Area and Severity Index (CLASI) Damage Score

Trial Design

1Treatment groups
Experimental Treatment
Group I: UVA1 treatmentExperimental Treatment1 Intervention
Low-dose UVA1 will be applied to active cutaneous lupus lesions three times a week for 10 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
UVA1 radiation treatment
2012
N/A
~10

Find a Location

Who is running the clinical trial?

Ben ChongLead Sponsor
Daavlin CorporationUNKNOWN
Benjamin F Chong, MD, MSCSPrincipal InvestigatorUniversity of Texas Southwestern Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025